![](/img/cover-not-exists.png)
Early Disease Activity or Clinical Response Predict Long-Term Outcomes with Certolizumab Pegol in Axial Spondyloarthritis or Psoriatic Arthritis
van der Heijde, D., Deodhar, A., Fleischmann, R., Mease, P. J., Rudwaleit, M., Nurminen, T., Davies BPharm, O.Language:
english
Journal:
Arthritis Care & Research
DOI:
10.1002/acr.23092
Date:
September, 2016
File:
PDF, 1.27 MB
english, 2016